Results
1 -
10 of
22
(Click
here to explore results)
- Epigenetics for Drug Discovery, CHAPTER 5 Targeting Histone Acetylation. Daniel Vitt, Roland Baumgartner, Hella Kohlhof
, 2016
, Pages 96-126
- Macrocycles in Drug Discovery, CHAPTER 4 Macrocyclic Inhibitors of Zinc-dependent Histone Deacetylases (HDACs). A. Ganesan
, 2015
, Pages 109-140
- Epigenetics for Drug Discovery, CHAPTER 12 Safety Considerations for Epigenetic Mechanisms as Drug Targets: Are Existing Toxicology Studies Fit for Purpose?. Paul Butler, Michael Lawton, Robert E. Chapin, Brett D. Hollingshead, Karen Leach, Prashant R. Nambiar, Mathew Pletcher, Amy H. Yang
, 2016
, Pages 288-315
- Peptide-based Drug Discovery: Challenges and New Therapeutics, CHAPTER 10 Peptide Therapeutics: Oncology. Ruiwu Liu, Xiaocen Li, Tsung-Chieh Shih, Joyce S. Lee, Kit S. Lam
, 2017
, Pages 278-325
- Epigenetics for Drug Discovery, CHAPTER 9 Who will Benefit from Epigenetic Drugs?. Dominique Verhelle, David J. Shields
, 2016
, Pages 230-248
- Polyamine Drug Discovery, Chapter 10 The Design and Development of Polyamine-Based Analogs with Epigenetic Targets. Yi Huang, Laurence J. Marton, Patrick M. Woster
, 2012
, Pages 238-256
- Anti-aging Drugs: From Basic Research to Clinical Practice, CHAPTER 21 HDAC Inhibitors: A New Avenue in Anti-Aging Medicine. E. G. Pasyukova, A. M. Vaiserman
, 2017
, Pages 514-534
- Macrocycles in Drug Discovery, CHAPTER 1 Bioactive Macrocycles from Nature. David J. Newman, Gordon M. Cragg
, 2015
, Pages 1-36
- Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 12 The Cancer Super-chaperone Hsp90: Drug Targeting and Post-translational Regulation. Annerleim Walton-Diaz, Sahar Khan, Jane B. Trepel, Mehdi Mollapour, Len Neckers
, 2014
, Pages 318-335
- Detection Methods in Precision Medicine, CHAPTER 15 Precision Oncology. Matthew R. Liebers
, 2021
, Pages 345-362